Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2015 | 1 |
2017 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Are IL-1 family cytokines important in management of sickle cell disease in Sub-Saharan Africa patients?
Front Immunol. 2023 Mar 9;14:954054. doi: 10.3389/fimmu.2023.954054. eCollection 2023.
Front Immunol. 2023.
PMID: 36969226
Free PMC article.
Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiation.
Gabillard D, N'Takpé JB, Chaix ML, Kouame GM, Moh R, Toni TD, Le Carrou J, Karcher S, Badje A, Emieme A, Menan H, Danel C, Anglaret X, Eholié SP; Temprano ANRS 12136 study group.
Gabillard D, et al.
J Antimicrob Chemother. 2021 Sep 15;76(10):2666-2674. doi: 10.1093/jac/dkab225.
J Antimicrob Chemother. 2021.
PMID: 34533197
Clinical Trial.
Item in Clipboard
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
TEMPRANO ANRS 12136 Study Group; Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X.
TEMPRANO ANRS 12136 Study Group, et al. Among authors: seri j.
N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.
N Engl J Med. 2015.
PMID: 26193126
Free article.
Clinical Trial.
Item in Clipboard
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
Badje A, Moh R, Gabillard D, Guéhi C, Kabran M, Ntakpé JB, Carrou JL, Kouame GM, Ouattara E, Messou E, Anzian A, Minga A, Gnokoro J, Gouesse P, Emieme A, Toni TD, Rabe C, Sidibé B, Nzunetu G, Dohoun L, Yao A, Kamagate S, Amon S, Kouame AB, Koua A, Kouamé E, Daligou M, Hawerlander D, Ackoundzé S, Koule S, Séri J, Ani A, Dembélé F, Koné F, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatunde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Karcher S, Rouzioux C, Kouame A, Assi R, Bakayoko A, Domoua SK, Deschamps N, Aka K, N'Dri-Yoman T, Salamon R, Journot V, Ahibo H, Ouassa T, Menan H, Inwoley A, Danel C, Eholié SP, Anglaret X; Temprano ANRS 12136 Study Group.
Badje A, et al. Among authors: seri j.
Lancet Glob Health. 2017 Nov;5(11):e1080-e1089. doi: 10.1016/S2214-109X(17)30372-8.
Lancet Glob Health. 2017.
PMID: 29025631
Free article.
Clinical Trial.
Item in Clipboard
Sound and speech detection and classification in a Health Smart Home.
Fleury A, Noury N, Vacher M, Glasson H, Seri JF.
Fleury A, et al. Among authors: seri jf.
Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:4644-7. doi: 10.1109/IEMBS.2008.4650248.
Annu Int Conf IEEE Eng Med Biol Soc. 2008.
PMID: 19163751
Item in Clipboard
Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.
Danel C, Moh R, Chaix ML, Gabillard D, Gnokoro J, Diby CJ, Toni T, Dohoun L, Rouzioux C, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 Trial Group.
Danel C, et al.
J Infect Dis. 2009 Jan 1;199(1):66-76. doi: 10.1086/595298.
J Infect Dis. 2009.
PMID: 18986246
Clinical Trial.
Item in Clipboard
Cite
Cite